Wutah bathi EPS kuartalan alnylam.com (ALNY)

Simbol lan logo merek Alnylam Corp (ALNY)

Alnylam Pharmaceuticals (ALNY) management successfully combines scientific research with sales, confirming the effectiveness of RNA technologies. However, high R&D expenditures and trial risks create financial pressure. The company is currently scaling sales, which is gradually reducing unit costs. The quarterly EPS growth rate helps assess the impact of inflation on profitability, while the 754.70 mark serves as the current indicator on this chart.

ALNY: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan Alnylam 04.07.2022 - 17.11.2026

Alnylam Pharmaceuticals (ALNY) - rincian metrik lan laporan keuangan

- rega saham lan prakiraan rega para ahli:
Analisis wiwitan perusahaan:Alnylam Pharmaceuticals
Barang unggulan Alnylam Corp

Quarterly EPS growth measures the dynamics of net income per share, revealing the business's ability to overcome cost inflation. Analyzing the history of quarterly EPS changes allows one to distinguish sustainable scaling from temporary resource savings. A positive trend confirms the effectiveness of operational capital management. For Alnylam Pharmaceuticals (ALNY), this indicator reflects the success of its own science without external acquisitions. Profit growth here directly depends on global licensing alliances.

Karo sapa Alnylam Pharmaceuticals saingan

VRTX: Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Insmed Inc (INSM)|UTHR (United Therapeutics Corporation) - Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan BMRN (BioMarin)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan BBIO (BridgeBio)|BGM: Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Cogent Biosciences, Inc. COGT|XERS (Xeris Biopharma Inc) - Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Keros Therapeutics - Wutah bathi EPS kuartalan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan ARCT (Arcturus Therapeutics)|ETON: Wutah bathi EPS kuartalan|Kamada Ltd (KMDA) - Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Fulcrum Tx|ABEO: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Mereo BioPharma Group (MREO)|Wutah bathi EPS kuartalan protalix.com (PLX)|Wutah bathi EPS kuartalan PLRX (Pliant Therapeutics Inc)|Wutah bathi EPS kuartalan Applied Therapeutics APLT|RNTX - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi resik saben saham sajroning taun lumaku gelteq.com (GELS)|AYTU (aytubio.com) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Chemomab Therapeutics Ltd - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan SRXH|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan PLRZ|Wutah bathi EPS kuartalan AEZS|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan CYTH (Cyclo Therapeutics, Inc)|Inozyme Pharma - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Reneo Pharmaceuticals, Inc. (RPHM) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|COSCIENS Bio - Wutah bathi EPS kuartalan